Cartilage-like tissue engineering using silk scaffolds and mesenchymal stem cells. 2006

Sandra Hofmann, and Sven Knecht, and Robert Langer, and David L Kaplan, and Gordana Vunjak-Novakovic, and Hans P Merkle, and Lorenz Meinel
Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.

Silk fibroin scaffolds were studied as a new biomaterial option for tissue-engineered cartilage-like tissue. Human bone marrow-derived mesenchymal stem cells (MSCs) were seeded on silk, collagen, and crosslinked collagen scaffolds and cultured for 21 days in serum-free chondrogenic medium. Cells proliferated more rapidly on the silk fibroin scaffolds than on the collagen matrices. The total content of glycosaminoglycan deposition was three times higher on silk as compared to collagen scaffolds. Glycosaminoglycan deposition coincided with overexpression of collagen type II and aggrecan genes. Cartilage-like tissue was homogeneously distributed throughout the entire silk scaffolds, while on the collagen and crosslinked collagen systems tissue formation was restricted to the outer rim, leaving a doughnut appearance. Round or angular-shaped cells resided in deep lacunae in the silk systems and stained positively for collagen type II. The aggregate modulus of the tissue-engineered cartilage constructs was more than 2-fold higher than that of the unseeded silk scaffold controls. These results suggest that silk fibroin scaffolds are suitable biomaterial substrates for autologous cartilage tissue engineering in serum-free medium and enable mechanical improvements along with compositional features suitable for durable implants to generate or regenerate cartilage.

UI MeSH Term Description Entries
D002356 Cartilage A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE. Cartilages
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D047011 Silk A continuous protein fiber consisting primarily of FIBROINS. It is synthesized by a variety of INSECTS and ARACHNIDS.
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D059630 Mesenchymal Stem Cells Mesenchymal stem cells, also referred to as multipotent stromal cells or mesenchymal stromal cells are multipotent, non-hematopoietic adult stem cells that are present in multiple tissues, including BONE MARROW; ADIPOSE TISSUE; and WHARTON JELLY. Mesenchymal stem cells can differentiate into mesodermal lineages, such as adipocytic, osteocytic and chondrocytic. Adipose Tissue-Derived Mesenchymal Stem Cell,Adipose Tissue-Derived Mesenchymal Stromal Cell,Adipose-Derived Mesenchymal Stem Cell,Bone Marrow Mesenchymal Stem Cell,Mesenchymal Stromal Cell,Mesenchymal Stromal Cells,Multipotent Bone Marrow Stromal Cell,Multipotent Mesenchymal Stromal Cell,Adipose Tissue-Derived Mesenchymal Stem Cells,Adipose Tissue-Derived Mesenchymal Stromal Cells,Adipose-Derived Mesenchymal Stem Cells,Adipose-Derived Mesenchymal Stromal Cells,Bone Marrow Mesenchymal Stem Cells,Bone Marrow Stromal Cell,Bone Marrow Stromal Cells,Bone Marrow Stromal Cells, Multipotent,Bone Marrow Stromal Stem Cells,Mesenchymal Progenitor Cell,Mesenchymal Progenitor Cells,Mesenchymal Stem Cell,Mesenchymal Stem Cells, Adipose-Derived,Mesenchymal Stromal Cells, Multipotent,Multipotent Bone Marrow Stromal Cells,Multipotent Mesenchymal Stromal Cells,Stem Cells, Mesenchymal,Wharton Jelly Cells,Wharton's Jelly Cells,Adipose Derived Mesenchymal Stem Cell,Adipose Derived Mesenchymal Stem Cells,Adipose Derived Mesenchymal Stromal Cells,Adipose Tissue Derived Mesenchymal Stem Cell,Adipose Tissue Derived Mesenchymal Stem Cells,Adipose Tissue Derived Mesenchymal Stromal Cell,Adipose Tissue Derived Mesenchymal Stromal Cells,Mesenchymal Stem Cells, Adipose Derived,Progenitor Cell, Mesenchymal,Progenitor Cells, Mesenchymal,Stem Cell, Mesenchymal,Stromal Cell, Mesenchymal,Stromal Cells, Mesenchymal,Wharton's Jelly Cell,Whartons Jelly Cells
D018929 Cell Culture Techniques Methods for maintaining or growing CELLS in vitro. Cell Culture,Cell Culture Technique,Cell Cultures,Culture Technique, Cell,Culture Techniques, Cell
D020219 Chondrogenesis The formation of cartilage. This process is directed by CHONDROCYTES which continually divide and lay down matrix during development. It is sometimes a precursor to OSTEOGENESIS.

Related Publications

Sandra Hofmann, and Sven Knecht, and Robert Langer, and David L Kaplan, and Gordana Vunjak-Novakovic, and Hans P Merkle, and Lorenz Meinel
November 2004, Biotechnology and bioengineering,
Sandra Hofmann, and Sven Knecht, and Robert Langer, and David L Kaplan, and Gordana Vunjak-Novakovic, and Hans P Merkle, and Lorenz Meinel
December 2005, Biomaterials,
Sandra Hofmann, and Sven Knecht, and Robert Langer, and David L Kaplan, and Gordana Vunjak-Novakovic, and Hans P Merkle, and Lorenz Meinel
October 2004, Journal of biomedical materials research. Part A,
Sandra Hofmann, and Sven Knecht, and Robert Langer, and David L Kaplan, and Gordana Vunjak-Novakovic, and Hans P Merkle, and Lorenz Meinel
September 2016, The Indian journal of medical research,
Sandra Hofmann, and Sven Knecht, and Robert Langer, and David L Kaplan, and Gordana Vunjak-Novakovic, and Hans P Merkle, and Lorenz Meinel
January 2017, Avicenna journal of medical biotechnology,
Sandra Hofmann, and Sven Knecht, and Robert Langer, and David L Kaplan, and Gordana Vunjak-Novakovic, and Hans P Merkle, and Lorenz Meinel
March 2017, Journal of tissue engineering and regenerative medicine,
Sandra Hofmann, and Sven Knecht, and Robert Langer, and David L Kaplan, and Gordana Vunjak-Novakovic, and Hans P Merkle, and Lorenz Meinel
April 2016, Biomaterials,
Sandra Hofmann, and Sven Knecht, and Robert Langer, and David L Kaplan, and Gordana Vunjak-Novakovic, and Hans P Merkle, and Lorenz Meinel
February 2007, Biomaterials,
Sandra Hofmann, and Sven Knecht, and Robert Langer, and David L Kaplan, and Gordana Vunjak-Novakovic, and Hans P Merkle, and Lorenz Meinel
June 2010, Tissue engineering. Part A,
Sandra Hofmann, and Sven Knecht, and Robert Langer, and David L Kaplan, and Gordana Vunjak-Novakovic, and Hans P Merkle, and Lorenz Meinel
September 2006, Biomaterials,
Copied contents to your clipboard!